Responses
Abstracts
Ischemic
2.3. Treatment
O02 First in man study of OTR4132, a heparan sulfate mimetic neuroprotector, injected intra-arterially after endovascular thrombectomy in patients with acute ischemic stroke: the matriss trial
Compose a Response to This Article
Other responses
No responses have been published for this article.